Pacific Biosciences Of California (PACB) Research & Development (2016 - 2025)
Pacific Biosciences Of California (PACB) has 16 years of Research & Development data on record, last reported at $22.9 million in Q4 2025.
- For Q4 2025, Research & Development fell 16.7% year-over-year to $22.9 million; the TTM value through Dec 2025 reached $97.3 million, down 27.88%, while the annual FY2025 figure was $97.3 million, 27.88% down from the prior year.
- Research & Development reached $22.9 million in Q4 2025 per PACB's latest filing, roughly flat from $22.8 million in the prior quarter.
- Across five years, Research & Development topped out at $52.9 million in Q1 2022 and bottomed at $20.5 million in Q1 2021.
- Average Research & Development over 5 years is $36.3 million, with a median of $40.5 million recorded in 2021.
- Peak YoY movement for Research & Development: skyrocketed 157.63% in 2022, then crashed 46.3% in 2024.
- A 5-year view of Research & Development shows it stood at $42.6 million in 2021, then increased by 0.11% to $42.6 million in 2022, then rose by 4.51% to $44.5 million in 2023, then plummeted by 38.34% to $27.5 million in 2024, then dropped by 16.7% to $22.9 million in 2025.
- Per Business Quant database, its latest 3 readings for Research & Development were $22.9 million in Q4 2025, $22.8 million in Q3 2025, and $22.5 million in Q2 2025.